After the announcement of FDA approval of a new drug, shares of TherapeuticsMD(NASDAQ: TXMD), a biotech focused on women's health, fell as much as 10% in afternoon trading on Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,